BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17926322)

  • 1. ROC volumes--should they be used?
    McClish DK
    Biom J; 2007 Aug; 49(5):665-6; discussion 670-1. PubMed ID: 17926322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The umbrella volume: is it useful in applications?
    Martus P
    Biom J; 2007 Aug; 49(5):667-9; discussion 670-1. PubMed ID: 17926323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ROC umbrella volumes with an application to the assessment of lung cancer diagnostic markers.
    Alonzo TA; Nakas CT
    Biom J; 2007 Aug; 49(5):654-64. PubMed ID: 17726716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining multiple markers for classification using ROC.
    Ma S; Huang J
    Biometrics; 2007 Sep; 63(3):751-7. PubMed ID: 17825007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROC graphs for assessing the ability of a diagnostic marker to detect three disease classes with an umbrella ordering.
    Nakas CT; Alonzo TA
    Biometrics; 2007 Jun; 63(2):603-9. PubMed ID: 17688513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A parametric comparison of diagnostic accuracy with three ordinal diagnostic groups.
    Xiong C; van Belle G; Miller JP; Yan Y; Gao F; Yu K; Morris JC
    Biom J; 2007 Aug; 49(5):682-93. PubMed ID: 17763377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cut-off-independent tumour marker evaluation using ROC approximation.
    Bitterlich N; Schneider J
    Anticancer Res; 2007; 27(6C):4305-10. PubMed ID: 18214036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
    Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
    J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The infrared spectral signatures of disease: extracting the distinguishing spectral features between normal and diseased states.
    Diem M; Papamarkakis K; Schubert J; Bird B; Romeo MJ; Miljković M
    Appl Spectrosc; 2009 Nov; 63(11):307A-318A. PubMed ID: 19891826
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
    Yu J; Zhu T; Wang Z; Zhang H; Qian Z; Xu H; Gao B; Wang W; Gu L; Meng J; Wang J; Feng X; Li Y; Yao X; Zhu J
    Clin Cancer Res; 2007 Dec; 13(24):7296-304. PubMed ID: 18094410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermcidin identification from exhaled air for lung cancer diagnosis.
    Chang WC; Huang MS; Yang CJ; Wang WY; Lai TC; Hsiao M; Chen CH
    Eur Respir J; 2010 May; 35(5):1182-5. PubMed ID: 20436176
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging molecular biomarkers for early detection of lung cancer in patients at high risk.
    Price N
    Clin Lung Cancer; 2004 Nov; 6(3):145-8. PubMed ID: 15555214
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of non-parametric confidence intervals for the area under the ROC curve of a continuous-scale diagnostic test.
    Gengsheng Qin ; Hotilovac L
    Stat Methods Med Res; 2008 Apr; 17(2):207-21. PubMed ID: 18426855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified sign test for comparing paired ROC curves.
    Braun TM; Alonzo TA
    Biostatistics; 2008 Apr; 9(2):364-72. PubMed ID: 17925302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Implementation and application of a digital cytopathological lung cancer diagnosing system].
    Wang D; Ye YK; Zhang Y; Gao Y; Yang YB; Zhou Y; Guo AY; Zhao B; Zhu L; Chen SF; Shu ZQ; Qian XQ
    Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(20):1417-9. PubMed ID: 18241598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.
    Altimari A; Grigioni AD; Benedettini E; Gabusi E; Schiavina R; Martinelli A; Morselli-Labate AM; Martorana G; Grigioni WF; Fiorentino M
    Am J Clin Pathol; 2008 May; 129(5):756-62. PubMed ID: 18426736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes.
    Liu L; Liao GQ; He P; Zhu H; Liu PH; Qu YM; Song XM; Xu QW; Gao Q; Zhang Y; Chen WF; Yin YH
    Biochem Biophys Res Commun; 2008 Aug; 372(4):756-60. PubMed ID: 18514066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust combination of multiple diagnostic tests for classifying censored event times.
    Cai T; Cheng S
    Biostatistics; 2008 Apr; 9(2):216-33. PubMed ID: 18056687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.